Tianjin Tianyao Pharmaceuticals Unit's Antibiotic Passes Generic Drug Consistency Evaluation in China
Tianjin Tianyao Pharmaceuticals (SHA:600488) said subsidiary Hubei Jinyao's amikacin sulfate injection passed China's generic drug quality and efficacy consistency evaluation.The drug is indicated for serious infections caused by susceptible gram-negative bacilli and methicillin-susceptible Staphylococcus species, according to a Thursday filing with the Shanghai bourse.Shares of the pharmaceutical company were down 3% in recent trade.